13 results
8-K
EX-10.2
SHPH
Shuttle Pharmaceuticals Holdings Inc
13 Feb 24
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
8:00am
, customer, vendor and supplier lists and identification, channels of distribution, and terms of identification of proposed or actual contracts
8-K
EX-10.1
SHPH
Shuttle Pharmaceuticals Holdings Inc
30 Oct 23
Shuttle Pharma Advances Prostate Cancer Predictive Biomarker Program Through Exclusive License Agreement
5:14pm
of this Agreement or such time as supplier can no longer supply the License Product.
Georgetown shall have a royalty-free, perpetual, sublicensable, worldwide right
8-K
EX-10.1
SHPH
Shuttle Pharmaceuticals Holdings Inc
1 Nov 22
Shuttle Pharmaceuticals Appoints Bette Jacobs to its Board of Directors
9:00am
, strategies, forecasts, customer and supplier identities, characteristics and agreements.
b. Exclusions. Notwithstanding the foregoing, the term Confidential
S-1/A
EX-1.1
tj7edb19y0
23 Jun 22
IPO registration (amended)
5:24pm
S-1/A
EX-10.16
xwthmf
23 Jun 22
IPO registration (amended)
5:24pm
S-1
EX-10.28
fxmxf8y c8
3 Jun 22
IPO registration
5:32pm
S-1
EX-10.3
ddo 30u8sfl3di3
3 Jun 22
IPO registration
5:32pm
S-1
EX-10.14
tagtt p2kb76j9
3 Jun 22
IPO registration
5:32pm
DRS
EX-10.10
9yf4qqhen
16 Sep 19
Draft registration statement
12:00am
- Prev
- 1
- Next